Class II
Terminated
Theophylline (Anhydrous) Extended-Release Tablets, 400 mg, 100-count bottle, Rx Only, Manufactured by: Nostrum Laboratories, Inc., Kansas City, MO 64120, NDC 29033-001-01.
Why: CGMP Deviations: poor manufacturing practices resulted in Labeling: Incorrect or Missing Lot and/or Exp Date, product incorrectly labeled with incorrect lot and expiration date.
- Company
- Nostrum Laboratories Inc
Kansas City, MO, United States - Reported
- Apr 1, 2020
- Recall started
- Mar 6, 2020
- Ended
- Apr 1, 2022
- Where sold
- TN, MO
- Amount
- 4722 bottles
- Full product description
- Theophylline (Anhydrous) Extended-Release Tablets, 400 mg, 100-count bottle, Rx Only, Manufactured by: Nostrum Laboratories, Inc., Kansas City, MO 64120, NDC 29033-001-01.
- Lots / codes affected
- Lot: THE190501, Exp 11/2022
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.